Hyperfine Inc. (HYPR)
NASDAQ (NMS) NASDAQ (NMS) Primary 
Hyperfine, Inc. (HYPR) Q1 2025 Earnings Call Transcript
Hyperfine, Inc. (NASDAQ:HYPR ) Q1 2025 Earnings Conference Call May 13, 2025 4:30 PM ET Company Participants Webb Campbell - Investor Relations Maria Sainz - President and Chief Executive Officer Brett Hale - Chief Administrative Officer and Chief Financial Officer Conference Call Participants Frank Takkinen - Lake Street Yuan Zhi - B. Riley Securities Operator Thank you for standing by.
Hyperfine, Inc. (HYPR) Reports Q1 Loss, Lags Revenue Estimates
Hyperfine, Inc. (HYPR) came out with a quarterly loss of $0.12 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.14 per share a year ago.
HYPR Stock Jumps on NVIDIA Partnership to Advance AI Neuroimaging
Hyperfine partners with NVIDIA to integrate advanced AI into its Swoop MRI system, aiming to transform neuroimaging with faster and more accessible brain scan solutions.
Hyperfine, Inc. (HYPR) Q4 2024 Earnings Call Transcript
Hyperfine, Inc. (NASDAQ:HYPR ) Q4 2024 Results Conference Call March 17, 2025 4:30 PM ET Company Participants Marissa Bych - Gilmartin Group Maria Sainz - President and Chief Executive Officer Brett Hale - Chief Administrative Officer and Chief Financial Officer Conference Call Participants Brandon Carney - B. Riley Young Li - Jefferies Operator Ladies and gentlemen, thank you for standing by.
Hyperfine, Nvidia Partner To Make Brain MRIs More Affordable
Hyperfine, Inc. HYPR shares are surging on Monday.
Hyperfine, Inc. (HYPR) Q3 2024 Earnings Call Transcript
Hyperfine, Inc. (NASDAQ:HYPR ) Q3 2024 Earnings Conference Call November 12, 2024 4:30 PM ET Company Participants Marissa Bych - Gilmartin Group Maria Sainz - President and CEO Brett Hale - Chief Administrative Officer and CFO Conference Call Participants Yuan Zhi - B. Riley Operator Good afternoon.
Hyperfine, Inc. (HYPR) Reports Q3 Loss, Tops Revenue Estimates
Hyperfine, Inc. (HYPR) came out with a quarterly loss of $0.14 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.15 per share a year ago.
HYPR Achieves Positive Swoop System Data for ECMO: Stock to Rise?
Hyperfine announces a publication on using the Swoop system for patients on ECMO support. The study showed the safety of using an ultra-low-field portable brain MRI on patients undergoing ECMO.
Favorable Data on Swoop Portable MRI Likely to Support Hyperfine Stock
Compared to conventional MRI, which takes an average of 27.7 hours, the Swoop system of HYPR operates with a median time-to-scan of 2.5 hours.
Hyperfine, Inc. (HYPR) Q2 2024 Earnings Call Transcript
Hyperfine, Inc. (NASDAQ:HYPR ) Q2 2024 Earnings Call August 8, 2024 4:30 PM ET Company Participants Marissa Bych - Investor Relations Maria Sainz - President and Chief Executive Officer Brett Hale - Chief Administrative Officer and Chief Financial Officer Conference Call Participants Yuan Zhi - B. Riley Operator Good afternoon, and welcome to Hyperfine's Second Quarter 2024 Earnings Conference Call.
Hyperfine, Inc. (HYPR) Reports Q2 Loss, Tops Revenue Estimates
Hyperfine, Inc. (HYPR) came out with a quarterly loss of $0.14 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.15 per share a year ago.
Hyperfine's (HYPR) Swoop System Gets New FDA-Cleared Software
Hyperfine (HYPR) announces the receipt of FDA clearance for its ninth-generation AI-powered Swoop system software.
